Cost‐effectiveness analysis of phenotypic‐guided versus guidelines‐guided bronchodilator therapy in viral bronchiolitis

• Published in: Pediatric pulmonology Vol. 56; no. 1; pp. 187 - 195
• Main Authors: Rodriguez‐Martinez, Carlos E., Nino, Gustavo, Castro‐Rodriguez, Jose A., Perez, Geovanny F., Sossa‐Briceño, Monica P., Buendia, Jefferson A.
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.01.2021
• Subjects: Administration, Inhalation; Albuterol - therapeutic use; bronchiolitis; Bronchiolitis - therapy; Bronchiolitis - virology; Bronchiolitis, Viral - drug therapy; Bronchitis; Bronchodilator Agents - therapeutic use; Bronchodilators; Clinical practice guidelines; Cost analysis; Cost-Benefit Analysis; cost‐effectiveness; Electronic Health Records; Emergency Service, Hospital; Genotype & phenotype; Health Care Costs; Health economics; Hospitalization; Humans; Infant; phenotype; Respiratory therapy; United States > US; phenotype; clinical practice guidelines; cost-effectiveness; bronchiolitis; health economics

Objectives Although recent evidence suggests that management of viral bronchiolitis requires something other than guidelines‐guided therapy, there is a lack of evidence supporting the economic benefits of phenotypic‐guided bronchodilator therapy for treating this disease. The aim of the present stud...